Animal models of mucosal inflammation and their relation to human inflammatory bowel disease - PubMed (original) (raw)
Review
Animal models of mucosal inflammation and their relation to human inflammatory bowel disease
R S Blumberg et al. Curr Opin Immunol. 1999 Dec.
Erratum in
- Curr Opin Immunol 2000 Apr;12(2):226
Abstract
Animal models of inflammatory bowel disease (IBD) have been useful in the identification of those immune responses uniquely involved in IBD pathogenesis and in defining the important roles of environmental influences, such as normal luminal bacterial flora and the genetic composition of the host, in modifying IBD-associated inflammation. Recent studies have focused particular attention on CD4+ T cells which produce excessive quantities either of Th1 cytokines (IFN-gamma and TNF) directed by IL-12 or of a Th2 cytokine (IL-4), relative to the production of suppressive cytokines such as IL-10 and transforming growth factor beta. Such insights will be extremely beneficial in the development of novel approaches to the control of IBD-type inflammation, such as the use of anticytokine therapies and gene therapy, and finally, in the identification of the genetic abnormalities and the antigens driving the inflammation that underlies the human disease.
Similar articles
- Lessons from genetic models of inflammatory bowel disease.
Podolsky DK. Podolsky DK. Acta Gastroenterol Belg. 1997 Apr-Jun;60(2):163-5. Acta Gastroenterol Belg. 1997. PMID: 9260328 Review. - [Dysregulation of mucosal immunity and inflammatory bowel diseases].
Dohi T, Kiyono H. Dohi T, et al. Nihon Rinsho. 1998 Jun;56(6):1619-26. Nihon Rinsho. 1998. PMID: 9648492 Review. Japanese. - Biologic therapy for inflammatory bowel disease.
Ardizzone S, Bianchi Porro G. Ardizzone S, et al. Drugs. 2005;65(16):2253-86. doi: 10.2165/00003495-200565160-00002. Drugs. 2005. PMID: 16266194 Review. - Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases.
Sarra M, Monteleone I, Stolfi C, Fantini MC, Sileri P, Sica G, Tersigni R, Macdonald TT, Pallone F, Monteleone G. Sarra M, et al. Inflamm Bowel Dis. 2010 Aug;16(8):1332-9. doi: 10.1002/ibd.21238. Inflamm Bowel Dis. 2010. PMID: 20186935
Cited by
- Assaying macrophage activity in a murine model of inflammatory bowel disease using fluorine-19 MRI.
Kadayakkara DK, Ranganathan S, Young WB, Ahrens ET. Kadayakkara DK, et al. Lab Invest. 2012 Apr;92(4):636-45. doi: 10.1038/labinvest.2012.7. Epub 2012 Feb 13. Lab Invest. 2012. PMID: 22330343 Free PMC article. - Genome-wide association studies of inflammatory bowel disease in German shepherd dogs.
Peiravan A, Bertolini F, Rothschild MF, Simpson KW, Jergens AE, Allenspach K, Werling D. Peiravan A, et al. PLoS One. 2018 Jul 20;13(7):e0200685. doi: 10.1371/journal.pone.0200685. eCollection 2018. PLoS One. 2018. PMID: 30028859 Free PMC article. - Formation of B and T cell subsets require the cannabinoid receptor CB2.
Ziring D, Wei B, Velazquez P, Schrage M, Buckley NE, Braun J. Ziring D, et al. Immunogenetics. 2006 Sep;58(9):714-25. doi: 10.1007/s00251-006-0138-x. Epub 2006 Aug 19. Immunogenetics. 2006. PMID: 16924491 - Identification of the polymorphisms in IFITM1 gene and their association in a Korean population with ulcerative colitis.
Mo JS, Na KS, Yu JI, Chae SC. Mo JS, et al. Immunol Lett. 2013 Nov-Dec;156(1-2):118-22. doi: 10.1016/j.imlet.2013.09.026. Epub 2013 Oct 10. Immunol Lett. 2013. PMID: 24120510 Free PMC article. - A guide to histomorphological evaluation of intestinal inflammation in mouse models.
Erben U, Loddenkemper C, Doerfel K, Spieckermann S, Haller D, Heimesaat MM, Zeitz M, Siegmund B, Kühl AA. Erben U, et al. Int J Clin Exp Pathol. 2014 Jul 15;7(8):4557-76. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25197329 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials